After Bombay HC rap, FDA withdraws orders against Cipla, MCA eateries
The Bombay High Court criticized the Maharashtra Food and Drug Administration for its handling of enforcement orders against restaurants and a pharmaceutical facility. Following the court's warning of contempt, the FDA withdrew its suspension orders.
Why it matters
Highlights the role of the judiciary in checking regulatory overreach and ensuring administrative accountability in India.
MUMBAI: The Maharashtra Food and Drug Administration (FDA) on Saturday withdrew two enforcement orders after the Bombay high court pulled up the regulator over its handling of separate cases involving five MCA eateries and a Cipla facility in Pune.The court's observations came while hearing two matters — one concerning five restaurants at the Mumbai Cricket Association (MCA) premises in Bandra-Kurla Complex and the other involving Cipla Pharma & Life Sciences Ltd's facility in Pune.FDA withdraws action against MCA eateriesIn the MCA matter, the FDA told the court that it would withdraw its order suspending the operations of five restaurants after the bench warned of contempt action against the officials concerned.A fresh inspection found that the restaurants were 88 per cent compliant with food safety rules, the bench of Acting Chief Justice Ravindra Ghuge and Justice Gautam Ankhad noted.The eateries, however, faced a separate licensing issue as they were being operated…
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in